Login
Subscribe
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
drug development, clinical trials, infectious disease
Opinion: Emergency Use Authorizations Are a Threat to Science
Kevin J. Tracey and Christina Brennan | Dec 1, 2020 | 4 min read
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020 | 9 min read
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ashley P. Taylor | Nov 12, 2018 | 2 min read
The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.
Ebola Vaccines Protect Monkeys
Jef Akst | Apr 9, 2015 | 1 min read
Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.
To Finish Off Polio
Ashley P. Taylor | Jun 16, 2014 | 5 min read
Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.